Akorn, Inc. recalls RIFAMPIN FOR INJECTION USP, 600 mg*/vial, Rx Only. Mfd. for: Akorn, Inc., Lake Forest, IL 60045. NDC: 17478-151-42.
- Recall date
- August 20, 2015
- Source
- U.S. Food & Drug Administration (FDA) — enforcement report
- Recall number
- D-0231-2016
- FDA classification
- Class III
- Brand / firm
- Akorn, Inc.
- Sold / distributed
- US: Nationwide
Why it was recalled
Failed Impurity/Degradation Specifications: Out of Specifications result obtained for a known impurity.
Class III means the product violates regulations but is not likely to cause harm.
What was recalled
RIFAMPIN FOR INJECTION USP, 600 mg*/vial, Rx Only. Mfd. for: Akorn, Inc., Lake Forest, IL 60045. NDC: 17478-151-42.
Get recall alerts
Free email alert whenever Akorn, Inc. has a new recall — straight from official government data. Unsubscribe anytime.
More recalls from: Akorn, Inc.